When was Biorelate founded?

Biorelate was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Where is Biorelate located?

Biorelate is headquartered in Manchester, United Kingdom.

Who is the current CEO of Biorelate?

Daniel Jamieson of Biorelate. They have also founded 1 company.

Which legal entities is Biorelate associated with?

Biorelate is associated with BIORELATE LIMITED.

How many employees does Biorelate have?

As of Apr 30, 2026, the latest employee count at Biorelate is 38.

Is Biorelate a funded company?

Biorelate is a funded company, having raised a total of $8.74M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 06, 2016.

When was the latest funding round of Biorelate?

Biorelate's latest funding was a $***** Series A round on Nov 29, 2022, with participation from 4 investors.

Where does Biorelate rank among its competitors?

Biorelate ranks 3rd amongst 95 active competitors, of which 15 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was ArcaScience, which secured $7M in Jun, 2025.

Who are the top competitors of Biorelate?

Biorelate's top competitors include Giotto Technologies, Protocols.io and Zotero. Among them, ArcaScience secured the most recent funding round in June, 2025.

Biorelate - 2026 Company Profile, Team, Funding, Competitors & Financials

Biorelate is a series A company based in Manchester (United Kingdom), founded in 2014 by Daniel Jamieson. It operates as a Developer of an artificial intelligence platform for biomedical literature curation and knowledge graph construction. Biorelate has raised $8.74M in funding from YFM Equity Partners and Maven Capital Partners. The company has 95 active competitors, including 15 funded and 9 that have exited. Its top competitors include companies like Giotto Technologies, Protocols.io and Zotero.

Company Details

Developer of an artificial intelligence platform for biomedical literature curation and knowledge graph construction. This technology identifies and extracts cause-and-effect relationships from scientific literature to support drug discovery and biological research. The platform enables the analysis of connections between genes, diseases, and chemical entities to assist in target identification, biomarker selection, and indication expansion. By automating the processing of biomedical data, the system provides evidence-based insights for researchers and scientists.

Website: biorelate.com
Social
Email ID: *****@biorelate.com

Key Metrics

Founded Year

2014

Location

Manchester, United Kingdom

Stage

Series A

Total Funding

$8.74M in 4 rounds

Latest Funding Round

Series A, Nov 29, 2022, $*****

Investors

YFM Equity Partners & 12 more

Ranked

3^rd among 95 active competitors

Employee Count

38 as on Apr 30, 2026

Similar Companies

Innovaccer & 2429 more

View Biorelate's full profile

Biorelate is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BIORELATE LIMITED CIN: 09087514 , United Kingdom, Active	Jun 15, 2014	-	23 (As on Mar 31, 2022)

Biorelate has raised a total funding of $8.74M over 4 rounds. Its first funding round was on Mar 06, 2016. Its latest funding round was a Series A round on Nov 29, 2022 for $*****. 4 investors participated in its latest round. Biorelate has 8 institutional investors and 5 angel investors.

Here is the list of recent funding rounds of Biorelate:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 29, 2022	5557743	Series A	7004469	9471796	7722751	4049222
Feb 19, 2019	7395028	Grant (prize money)	6876070	4374533	3788673	Innovate UK
Sep 17, 2018	9806098	Seed	4114277	2819560	4652389	Maven Capital Partners & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of Biorelate's funding rounds and investors

The founders of Biorelate is Daniel Jamieson. Daniel Jamieson is the CEO of Biorelate.

Here are the details of Biorelate's key team members:

Daniel Jamieson: Founder & CEO of Biorelate.
Contact Info: 1 email address

View details of Biorelate's Founder profiles and Board Members

Biorelate's employee count trend

Biorelate has 38 employees as of Apr 26. Here is Biorelate's employee count trend over the years:

Uncover Biorelate's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biorelate include Giotto Technologies, Protocols.io and Zotero. Here is the list of Top 10 competitors of Biorelate, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Giotto Technologies 2017, Switzerland, Acquired	Developer of reasoning technology designed to advance artificial general intelligence	$5.02M	Faster Capital, Park House Partners	58/100
2nd	Protocols.io 2012, Berkeley (United States), Seed	Life science protocol repository	$500K	Lighthouse Capital Management, Berkeley SkyDeck	54/100
3rd	Biorelate 2014, Manchester (United Kingdom), Series A	Developer of an artificial intelligence platform for biomedical literature curation and knowledge graph construction	$8.74M	Triple Point, Innovate UK & 11 others	47/100
4th	Zotero 2007, Fairfax (United States), Unfunded	Research tool for collecting, organizing, citing, and sharing research	-	-	46/100
5th	ScienceIO 2020, Boston (United States), Acquired	Provider of AI solutions transforming medical text into enriched healthcare data	$8M	Sea Lane Ventures, Toba Capital & 12 others	46/100
6th	ArcaScience 2018, Paris (France), Seed	Developer of AI models for patient-centric insights in drug development	$7M	The Moon Venture, Bpifrance & 4 others	45/100
7th	Kudos 2013, Oxford (United Kingdom), Series A	Provider of research communication and showcase services. It helps researchers effectively communicate their work to a broader audience. The company offers tools and resources to enhance research visibility and impact. Services include creating engaging narratives around research findings and facilitating their dissemination across various platforms. This improves the reach and understanding of scientific discoveries.	$2.5M	Mobeus Equity Partners, Gleneagle Capital ... & 4 others	45/100
8th	StudyMode 1999, West Hollywood (United States), Unfunded	Essay examples and writing tools to fine-tune academic assignments	-	-	43/100
9th	Longenesis 2017, Riga (Latvia), Seed	Digital platform for healthcare research and patient engagement	$1.19M	MedTech Innovator, R3i Capital & 4 others	43/100
10th	Animares 1997, Bonn (Germany), Unfunded	Developer of 3D medical animations and augmented, mixed, virtual reality	-	-	42/100